Swiss Vaccine Research Institute

Recent papers from Swiss Vaccine Research Institute

1. ICH E21: from landmark guidance to specific action for maternal and child healthJournal of Translational Medicine · 2026
2. SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipientsVirology Journal · 2026
3. Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cellsEBioMedicine · 2024
4. SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responsesFrontiers in Immunology · 2024
5. A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal AntibodiesInfectious Diseases and Therapy · 2024
6. Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ARTCell Host & Microbe · 2023
7. A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cellsFrontiers in Immunology · 2023
8. ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys2023
9. Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19Journal of Clinical Immunology · 2023
10. CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral ResponsesViruses · 2022
11. Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccineFrontiers in Immunology · 2022
12. The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infectionFrontiers in Immunology · 2022
13. Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipientsFrontiers in Medicine · 2022
14. Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeysNature Microbiology · 2022
15. T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodelingNature Communications · 2022
16. Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised PatientsJAMA Oncology · 2022
17. Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsPLoS Pathogens · 2021
18. T cell receptor and IL-2 signaling strength control memory CD8 + T cell functional fitness via chromatin remodeling2021
19. A highly potent antibody effective against SARS-CoV-2 variants of concernCell Reports · 2021
20. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaquesNature Communications · 2021